Clinical Trials Directory

Trials / Completed

CompletedNCT02749929

Low-level Laser Therapy in Wrist Fractures

A Double-blind Placebo-controlled Study of Low-level Laser Therapy in Wrist Fractures

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
53 (actual)
Sponsor
University of Bergen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Approximately 15,000 persons in Norway suffer from wrist fractures during a year, making it the most prevalent fracture in this country. Treated conservatively, a cast is used for 4-6 weeks before removal. After discontinuation of the cast, physiotherapy is implemented to aid in improving range of motion and regaining function of the injured wrist. The pain after injury can affect the patient to a greater or lesser extent, and it is common to prescribe sick leave for shorter amounts of time after the injury. Studies suggest that a physiotherapy intervention with Low Level Laser therapy (LLLT) may reduce pain and swelling after acute trauma, and potentially promote healing. The aim of this study is to evaluate the effect of LLLT on pain and function at 2, 4, 8 and 26 weeks after injury.

Detailed description

Patients with wrist fractures are recruited from Bergen Municipal Emergency Ward, where they are randomly divided into two groups with concealed allocation. The fracture is immobilized with a cast, with a small opening where Low Level Laser therapy can be administered in skin contact. The patients will receive treatment 3 times a week, for 3 weeks. After discontinuation of the cast, the patients swelling, pain, grip strength and function of the wrist is measured. The patients will meet for follow-up controls until 26 weeks after injury.

Conditions

Interventions

TypeNameDescription
OTHERLow level laser therapyThe laser is an infrared (invisible) 60 mW 904 nm Irradia Midlaser
OTHERPlacebo Low Level Laser TherapyThe placebo laser is an identical device to the active laser, made by Irradia Midlaser

Timeline

Start date
2016-04-01
Primary completion
2020-11-30
Completion
2021-04-27
First posted
2016-04-25
Last updated
2021-04-30

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT02749929. Inclusion in this directory is not an endorsement.